WithdrawnNot Applicable

Serum Bupivacaine Concentration Levels After Intermittent Bolus Injections Via Erector Spinae Plane Peripheral Catheter

Stopped: No immediate plans to start the study. Issues with testing materials.

United States0Started 2025-01-01

Plain-language summary

The purpose of this study is to evaluate the serum bupivacaine concentrations over time after 0.125% bupivacaine is deposited every 6 hours in the erector spinae plane in patients who undergo unilateral VATS.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * at least 18 years of age * having a unilateral video assisted thorascopic surgery who have preoperative placement of an erector spinae plane catheter. Exclusion Criteria: * Known hepatic dysfunction or renal insufficiency (creatinine \>1.5 mg/dL) * allergy to the study medication * pregnancy * incarceration * inability to communicate with the investigators * morbid obesity (body mass index \>40 mg/m2).

What they're measuring

Change in pharmacokinetics of bupivacaine placed in the erector spinae plane between 6 time points

Timeframe: 30, 60, 90, 120, 240 and 360 minutes following the initial, 2nd and 5th boluses.

Trial details

NCT IDNCT05038956

SponsorUniversity of Utah

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-01

View on ClinicalTrials.gov More Video-assisted Thoracic Surgery (VATS) trials